How to Take Advantage of the M&A Boom
Mergers and acquisitions are becoming ever more popular, with activity up 24% in the first two months of this year -- after already growing 23% in 2010. Here's how your portfolio can benefit from this trend.
jj
Johnson & Johnson Recalls Leaky Insulin Cartridges
Johnson & Johnson has issued another recall, and this time, it's not over a typo. The company's Animas unit recalled five lots of leaking insulin cartridges whose use could lead to serious health problems. The 2-milliliter cartridges can leak, resulting in the delivery of less insulin than intended.
Ortho Ordered to Pay $1.7 Million in Levaquin Lawsuit
On Wednesday, a Minneapolis jury ordered Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals to pay an 87-year-old man $1.7 million because its antibiotic Levaquin damaged his Achilles tendons. It was the first verdict from about 2,600 similar lawsuits filed so far.
Big in Japan: Johnson & Johnson's Contact Lens Recall
Johnson & Johnson expanded its recall of Acuvue TruEye contact lenses fivefold back in October, but only announced the news in Japan, where most of the recalled lenses were sold.
J&J to Acquire Vaccine Maker Crucell
Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.
Johnson & Johnson CEO to Apologize for Recalls
CEO William Weldon will apologize to Congress for a series of product recalls over the past year. The company is also expected to resume shipments of children's cold medication next week.
Was Johnson & Johnson aware of problems with its Children's Tylenol months before the recall? The House Oversight Committee has invited an FDA commissioner and Johnson & Johnson chairman to a hearing next week to address this and other questions surrounding the massive recall of children's medicines earlier this year.
Johnson & Johnson Execs to Be Grilled Over Recall
It's been about a month since Johnson & Johnson issued the largest-ever recall of children's medicine, but the fallout may be just beginning. Representatives from both J&J and the FDA are scheduled to testify at a May 27 congressional hearing as lawmakers remain concerned about how the recall was handled.
Johnson & Johnson Fights Charges of Recalls and Kickbacks
Johnson & Johnson shares are rebounding as the drug maker recovers from federal charges it paid kickbacks to a pharmacy company to boost sales of its drugs to nursing-home patients. Meantime, the Food and Drug Administration accused it of being too slow with its product recall during a Tylenol scare.